Cas:14774-36-8 Tetrahydro-2H-pyran-3-ylmethanol manufacturer & supplier

Chemical Name:Tetrahydro-2H-pyran-3-ylmethanol

CAS.NO:14774-36-8

Synonyms:tetrahydropyran-3-yl-methanol;tetrahydropyran-3-carbinol;2H-Pyran-3-methanol, tetrahydro-;3-Hydroxymethyl-tetrahydro-pyran;(tetrahydro-2H-pyran-3-yl)methanol;2H-3,4,5,6-tetrahydropyran-3-ylmethan-1-ol;tetrahydropyran-3-methanol;Tetrahydro-2H-pyran-3-ylmethanol;tetrahydro-2H-pyran-3-methanol

Molecular Formula:C₆H₁₂O₂

Molecular Weight:116.158

HS Code:2932999099

Physical and Chemical Properties:

Melting point:N/A

Boiling point:214.3±8.0 °C at 760 mmHg

Density:1.0±0.1 g/cm3

Index of Refraction:1.445

PSA:29.46000

Exact Mass:116.083733

LogP:-0.32

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like tetrahydropyran-3-yl-methanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tetrahydro-2H-pyran-3-methanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2H-3,4,5,6-tetrahydropyran-3-ylmethan-1-ol Use and application,tetrahydro-2H-pyran-3-methanol technical grade,usp/ep/jp grade.

Related News: In picking McNamara for the over-the-counter unit, GSK is once again de facto standing behind Walmsley as the captain of the remaining pharma, which will stay focused on therapeutics and vaccines, despite pressure from Elliott Management to shuffle its top ranks. N,N’-bis[bis(aziridin-1-yl)phosphinothioyl]pentane-1,5-diamine manufacturers As Natural Capsules did not have access to this manufacturing technology, its R&D centre, which is DSIR approved, had started working on the same since 2018, and has now successfully developed the process including fermentation and chemical synthesis steps, Sunil Mundra, managing director, Natural Capsules told Pharmabiz. N-hydroxy-1-((4-(4-methoxyphenoxy)phenyl)sulfonyl)-4-(methylsulfonyl)piperazine-2-carboxamide suppliers Immunocompromised people account for roughly 2.7% of U.S. adults including patients who’ve received an organ transplant, living with HIV or have received active or recent treatment for cancer, Oliver said. 2-((3-fluorophenyl)amino)-5-methyl-5-nitro-1,3,2-dioxaphosphinane 2-oxide vendor & factory In picking McNamara for the over-the-counter unit, GSK is once again de facto standing behind Walmsley as the captain of the remaining pharma, which will stay focused on therapeutics and vaccines, despite pressure from Elliott Management to shuffle its top ranks.,but are not expected to recover the costs of developing and marketing a treatment drug.” Due to the high costs and low demands of the drug product, it is important to efficiently use API supply during the formulation process.